Latest news with #medication
Yahoo
3 hours ago
- Health
- Yahoo
1
The UK is heading for its second heatwave of the summer, and we're only one month in. The Met Office advises: 'The hottest day of the current spell is expected on Monday, with temperatures widely exceeding 30°C in central and eastern England, possibly reaching 34°C in London'. But, before you rush out in sunnies and shorts, it might be a good idea to check your medicine cabinet: research has found that certain medications can have physiological effects on the body, causing the core body temperature to rise above 40°C. Other medications have been found to make people far more sensitive to heat. According to the Mental Health Foundation: 'One adult in eight receives mental health treatment, with 10.4% [of those] receiving medication and 3% receiving psychological therapy. 'The overlap within the statistics is due to 1.3% of those receiving treatment reporting receiving both medication and psychological therapy.' Mental health medications fall under a number of different categories including Serotonin Reuptake Inhibitors (SSRIs), Tricyclic Antidepressants (TCAs) Antipsychotic Drugs (ACDs), and beta blockers which are often used to treat anxiety and heart conditions. All of these medications can cause heat intolerance. Additionally, blood pressure medications can cause heat intolerance, too. According to Centers for Disease Control: 'Certain combinations of medications, such as the combined use of angiotensin converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB) with a diuretic, may significantly increase risk of harm from heat exposure.' To stay cool during hot weather, the NHS recommends: 'Keep out of the heat if you can. If you have to go outside, stay in the shade especially between 11am and 3pm, wear sunscreen, a hat and light clothes, and avoid exercise or activity that makes you hotter. 'Cool yourself down. Have cold food and drinks, avoid alcohol, caffeine and hot drinks, and have a cool shower or put cool water on your skin or clothes.' They also advise keeping windows closed during the day and opened at night once temperatures have somebody potentially experiencing heat exhaustion, the health service advises the following tips: Move them to a cool place Remove all unnecessary clothing like a jacket or socks Get them to drink a sports or rehydration drink, or cool water Cool their skin – spray or sponge them with cool water and fan them. Cold packs, wrapped in a cloth and put under the armpits or on the neck are good too This Is One Of The Worst Things You Can Do To Gardens In A Heatwave The Unexpected Effect Heatwaves Have On Your Phone's Signal So, Should You Actually Close Your Windows During A Heatwave?
Yahoo
3 hours ago
- Health
- Yahoo
1
The UK is heading for its second heatwave of the summer, and we're only one month in. The Met Office advises: 'The hottest day of the current spell is expected on Monday, with temperatures widely exceeding 30°C in central and eastern England, possibly reaching 34°C in London'. But, before you rush out in sunnies and shorts, it might be a good idea to check your medicine cabinet: research has found that certain medications can have physiological effects on the body, causing the core body temperature to rise above 40°C. Other medications have been found to make people far more sensitive to heat. According to the Mental Health Foundation: 'One adult in eight receives mental health treatment, with 10.4% [of those] receiving medication and 3% receiving psychological therapy. 'The overlap within the statistics is due to 1.3% of those receiving treatment reporting receiving both medication and psychological therapy.' Mental health medications fall under a number of different categories including Serotonin Reuptake Inhibitors (SSRIs), Tricyclic Antidepressants (TCAs) Antipsychotic Drugs (ACDs), and beta blockers which are often used to treat anxiety and heart conditions. All of these medications can cause heat intolerance. Additionally, blood pressure medications can cause heat intolerance, too. According to Centers for Disease Control: 'Certain combinations of medications, such as the combined use of angiotensin converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB) with a diuretic, may significantly increase risk of harm from heat exposure.' To stay cool during hot weather, the NHS recommends: 'Keep out of the heat if you can. If you have to go outside, stay in the shade especially between 11am and 3pm, wear sunscreen, a hat and light clothes, and avoid exercise or activity that makes you hotter. 'Cool yourself down. Have cold food and drinks, avoid alcohol, caffeine and hot drinks, and have a cool shower or put cool water on your skin or clothes.' They also advise keeping windows closed during the day and opened at night once temperatures have somebody potentially experiencing heat exhaustion, the health service advises the following tips: Move them to a cool place Remove all unnecessary clothing like a jacket or socks Get them to drink a sports or rehydration drink, or cool water Cool their skin – spray or sponge them with cool water and fan them. Cold packs, wrapped in a cloth and put under the armpits or on the neck are good too This Is One Of The Worst Things You Can Do To Gardens In A Heatwave The Unexpected Effect Heatwaves Have On Your Phone's Signal So, Should You Actually Close Your Windows During A Heatwave?
Irish Times
a day ago
- Health
- Irish Times
Woman allegedly suffered stroke after taking migraine medication bought from Boots pharmacy
A woman who claimed she suffered a brain bleed and stroke after taking migraine medication she bought at a Boots outlet has settled a High Court action against the pharmacy giant. Ms Justice Denise Brett was told on the third day of Sigrid O'Meara's action that the case had been settled without an admission of liability. In the proceedings, it was claimed the medication was inappropriately sold to Ms O'Meara (63) and there was an alleged failure to advise her the migraine medication is contraindicated with an anti-antidepressant she was taking. This is due to a significant interaction between the two medications which, it was claimed, can lead to significant increase in blood pressure and stroke, the court heard. READ MORE All of the claims were denied by Boots. The company says protocol dictates that anyone purchasing the migraine medication in question is referred to a pharmacist. Ms O'Meara claimed she took the migraine medication when she woke with a headache on March 26th, 2020. She took two tablets she had purchased from a Boots pharmacy in Longford the previous October. It was contended that she felt dizzy, collapsed and had to be brought by ambulance to hospital. A scan showed she had a brain bleed and she was transferred to a Dublin hospital. Ms O'Meara, from Ballincurry, Co Longford , was discharged from hospital a month later and was recorded as having severe left leg weakness and difficulties with her left arm. She had to go for rehabilitation. She sued Boots Retail (Ireland) Ltd, with a registered address at Citywest Business Campus, Citywest, Dublin. She claims she bought the migraine medication at Boots Pharmacy, Ballymahon Street, Longford. It was claimed that that Ms O'Meara was caused to suffer a haemorrhagic stroke in March 2020 which, it was contended, was precipitated by her ingestion of a migraine medication allegedly inappropriately sold without the advice that it was contraindicated to a prescribed drug she was already taking. It was claimed she was told at the pharmacy that the migraine medication she required was no longer available in Ireland and an alternative medication for migraines and cluster headaches was allegedly offered. Ms O'Meara purchased a blister pack of two tablets and it was alleged the pharmacist was not consulted. Boots disputed this and said while they did not remember Ms O'Meara, protocol requires that anybody buying the migraine medicine has to be referred to the pharmacist. In the proceedings, it was claimed that a product which allegedly could impose a hazard to Ms O'Meara's health was supplied and there was an alleged failure by the pharmacy sales assistant at the time to ensure the pharmacist was advised that the supply of the particular migraine medication may be considered. It was further claimed there was an alleged failure by the pharmacist to ascertain that the woman's headache had never been diagnosed as migraine by a doctor. It was contended, in such circumstances, the migraine medication she purchased should not have been supplied. All of the claims were denied. Boots said Ms O'Meara was aware the medication purchased at the pharmacy had never been deemed as suitable for her and she had a significant history of migraines, and other medical issues, which Boots claims was her responsibility to notify and seek advice on. Boots said it had no other way of being aware Ms O'Meara was taking a form of medication which was likely to interact negatively with a variety of different medication. Ms O'Meara, Boots contended, was the author of her own misfortune. It claimed there was alleged contributory negligence on her part in failing to disclose that she was taking another particular drug and failing to seek advice on the choice of medicines.
BreakingNews.ie
a day ago
- Health
- BreakingNews.ie
Woman who sued Boots pharmacy settles High Court action
A woman who claimed she suffered a brain bleed and stroke after taking migraine medication she bought at a Boots pharmacy has settled a High Court action against the pharmacy giant. Ms Justice Denise Brett, on the third day of the action, was told the case had been settled. The settlement is without an admission of liability. Advertisement In the proceedings, it was claimed that the medication was allegedly inappropriately sold to Sigrid O'Meara, and there was an alleged failure to advise her that the migraine medication is contraindicated with an antidepressant drug she was taking. This is due to a significant interaction between the two medications, which it was claimed can lead to a significant increase in blood pressure and stroke. All of the claims were vehemently denied by Boots. It said it could not remember Ms O'Meara but said protocol dictates that anyone purchasing that €11.99 migraine medication is referred to a pharmacist. Sigrid O'Meara had taken the migraine medication when she woke with a terrible headache on March 26, 2020. She took two tablets she had purchased from a Longford Boots pharmacy the previous October. Advertisement It was further contended that she felt dizzy and collapsed and had to be brought by ambulance to hospital. A scan showed she had a brain bleed, and she was transferred to a Dublin hospital. She was discharged from hospital a month later and was recorded as having severe left leg weakness, difficulties with her left arm and had to go for rehabilitation. Sigrid O'Meara (63), from Ballincurry, Longford has sued Boots Retail (Ireland) Ltd with a registered address at Citywest Business Campus, Citywest, Dublin. She claims she bought the migraine medication at Boots Pharmacy, Ballymahon Street, Longford. It was claimed that Ms O'Meara was caused to suffer a haemorrhagic stroke in March 2020, which it was contended, was precipitated by her ingestion of a migraine medication which was allegedly inappropriately sold allegedly without the advice that it was contraindicated to a prescribed drug she was already on. Advertisement It was claimed that at the pharmacy, she was allegedly told that the migraine medication she required was no longer available in Ireland, and an alternative medication for migraines and cluster headaches was allegedly offered. Ms O'Meara purchased a blister pack of two tablets, and it was alleged that the pharmacist was not consulted. Boots disputed this and said while they did not remember Ms O'Meara, protocol requires that anybody buying the migraine medicine has to be referred to the pharmacist. In the proceedings it was claimed that a product which allegedly could impose a hazard to Ms O'Meara's health was supplied and there was an alleged failure by the pharmacy sales assistant at the time to ensure the pharmacist was advised that the supply of that particular migraine medication may be considered. Advertisement It was further claimed that there was an alleged failure by the pharmacist to ascertain that the woman's headache had never been diagnosed as migraine by a doctor. It was contended in such circumstances, the migraine medication she purchased should not have been supplied. All of the claims were denied, and Boots said that Ms O'Meara was aware that the medication purchased at the pharmacy had never been diagnosed as suitable for her and that she had a significant history of migraines as well as other medical issues, which Boots claims was her responsibility to notify and seek advice on. Boots said it had no other way of being aware Ms O'Meara was taking a form of medication which was likely to interact negatively with a variety of different medications. Ms O'Meara, Boots contended, was the author of her own misfortune, and it claimed there was alleged contributory negligence on her part in allegedly failing to disclose that she was taking another particular drug and allegedly failing to seek advice on the choice of medicines.
The Guardian
a day ago
- Health
- The Guardian
Australians with ADHD could face drug shortages for rest of year, TGA says
People with attention deficit hyperactivity disorder are being advised to contact their doctor as Australia's drug regulator warned a common medication used to treat the condition may be in short supply for the rest of the year. Methylphenidate – known by its brand names as Ritalin, Ritalin LA and Concerta – is in short supply in Australia due to manufacturing issues, according to a notice from the Therapeutic Goods Administration on Wednesday, which advised people to speak to their pharmacist to help source their prescription. ADHD drug shortages have been an ongoing problem in Australia for a number of months. But Prof Dave Coghill, Chair of Development Mental Health at the University of Melbourne, is warning people who live with ADHD not to panic, saying not all forms of ADHD medication are currently experiencing a shortage. He said methylphenidate is only one of four medications used to treat ADHD, and even within that class of drug, there is not a complete shortage but a shortage of some brands at some doses. Sign up for Guardian Australia's breaking news email 'The problem we have is the ones that are in shortage are changing constantly so it's very difficult to predict from one week to the next which medications are going to be available,' Coghill said, adding people who live with ADHD should speak with their doctor to work out a good alternative medication. ADHD is a neurodevelopmental disorder that affects how the brain develops, processes and handles information. About one in 20 Australians have it. 'People who live with ADHD have problems in three main areas, which is difficulty with attention/concentration, focus and planning,' Coghill said. 'They often have problems with overactivity and restlessness … and they also often have impulsivity or impulsiveness.' Coghill said medication shortages can be challenging. 'We've now got good evidence to show that the ADHD medications not only help you concentrate and focus but help you to stop and think before you act,' Coghill said. Sign up to Breaking News Australia Get the most important news as it breaks after newsletter promotion 'So they don't just make people feel better, but actually they help people live safer, more productive lives, and ADHD medications are really a key to helping people manage those symptoms.' A massive increase in demand globally for ADHD drugs as well as restrictions placed on the manufacture of one of the core ingredients by the US Drug Enforcement Agency has led to the shortages, Coghill said. The TGA has convened a medicine shortage action group with health professional and peak body groups to help manage the ongoing shortages..
